188 related articles for article (PubMed ID: 9099760)
1. Osteogenesis imperfecta in childhood: impairment and disability.
Engelbert RH; van der Graaf Y; van Empelen R; Beemer FA; Helders PJ
Pediatrics; 1997 Feb; 99(2):E3. PubMed ID: 9099760
[TBL] [Abstract][Full Text] [Related]
2. Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up.
Engelbert RH; Uiterwaal CS; Gerver WJ; van der Net JJ; Pruijs HE; Helders PJ
Arch Phys Med Rehabil; 2004 May; 85(5):772-8. PubMed ID: 15129402
[TBL] [Abstract][Full Text] [Related]
3. Osteogenesis imperfecta in childhood: perceived competence in relation to impairment and disability.
Engelbert RH; Gulmans VA; Uiterwaal CS; Helders PJ
Arch Phys Med Rehabil; 2001 Jul; 82(7):943-8. PubMed ID: 11441383
[TBL] [Abstract][Full Text] [Related]
4. Osteogenesis imperfecta in childhood: impairment and disability--a follow-up study.
Engelbert RH; Beemer FA; van der Graaf Y; Helders PJ
Arch Phys Med Rehabil; 1999 Aug; 80(8):896-903. PubMed ID: 10453765
[TBL] [Abstract][Full Text] [Related]
5. Muscle strength, joint range of motion, and gait in children and adolescents with osteogenesis imperfecta.
Brizola E; Staub AL; Félix TM
Pediatr Phys Ther; 2014; 26(2):245-52. PubMed ID: 24675130
[TBL] [Abstract][Full Text] [Related]
6. Osteogenesis imperfecta in childhood: treatment strategies.
Engelbert RH; Pruijs HE; Beemer FA; Helders PJ
Arch Phys Med Rehabil; 1998 Dec; 79(12):1590-4. PubMed ID: 9862306
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary Treatment of Severe Osteogenesis Imperfecta: Functional Outcomes at Skeletal Maturity.
Montpetit K; Palomo T; Glorieux FH; Fassier F; Rauch F
Arch Phys Med Rehabil; 2015 Oct; 96(10):1834-9. PubMed ID: 26140741
[TBL] [Abstract][Full Text] [Related]
8. The functional muscle-bone unit in patients with osteogenesis imperfecta type I.
Veilleux LN; Pouliot-Laforte A; Lemay M; Cheung MS; Glorieux FH; Rauch F
Bone; 2015 Oct; 79():52-7. PubMed ID: 26004918
[TBL] [Abstract][Full Text] [Related]
9. Gait characteristics and functional assessment of children with type I osteogenesis imperfecta.
Graf A; Hassani S; Krzak J; Caudill A; Flanagan A; Bajorunaite R; Harris G; Smith P
J Orthop Res; 2009 Sep; 27(9):1182-90. PubMed ID: 19242979
[TBL] [Abstract][Full Text] [Related]
10. Gait Deviations in Children With Osteogenesis Imperfecta Type I.
Garman CR; Graf A; Krzak J; Caudill A; Smith P; Harris G
J Pediatr Orthop; 2019 Sep; 39(8):e641-e646. PubMed ID: 31393309
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.
Letocha AD; Cintas HL; Troendle JF; Reynolds JC; Cann CE; Chernoff EJ; Hill SC; Gerber LH; Marini JC
J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life of children and adolescents with osteogenesis imperfecta: a cross-sectional study using PedsQL™.
Vanz AP; van de Sande Lee J; Pinheiro B; Zambrano M; Brizola E; da Rocha NS; Schwartz IVD; de Souza Pires MM; Félix TM
BMC Pediatr; 2018 Mar; 18(1):95. PubMed ID: 29499676
[TBL] [Abstract][Full Text] [Related]
13. Muscle Function in Osteogenesis Imperfecta Type IV.
Veilleux LN; Darsaklis VB; Montpetit K; Glorieux FH; Rauch F
Calcif Tissue Int; 2017 Oct; 101(4):362-370. PubMed ID: 28474170
[TBL] [Abstract][Full Text] [Related]
14. Osteogenesis imperfecta in childhood: prognosis for walking.
Engelbert RH; Uiterwaal CS; Gulmans VA; Pruijs H; Helders PJ
J Pediatr; 2000 Sep; 137(3):397-402. PubMed ID: 10969267
[TBL] [Abstract][Full Text] [Related]
15. Osteogenesis imperfecta: profiles of motor development as assessed by a postal questionnaire.
Engelbert RH; Uiterwaal CS; Gulmans VA; Pruijs HE; Helders PJ
Eur J Pediatr; 2000 Aug; 159(8):615-20. PubMed ID: 10968241
[TBL] [Abstract][Full Text] [Related]
16. Activities and participation in young adults with osteogenesis imperfecta.
Montpetit K; Dahan-Oliel N; Ruck-Gibis J; Fassier F; Rauch F; Glorieux F
J Pediatr Rehabil Med; 2011; 4(1):13-22. PubMed ID: 21757806
[TBL] [Abstract][Full Text] [Related]
17. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Land C; Rauch F; Travers R; Glorieux FH
Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
[TBL] [Abstract][Full Text] [Related]
18. Spinal complications in osteogenesis imperfecta: 47 patients 1-16 years of age.
Engelbert RH; Gerver WJ; Breslau-Siderius LJ; van der Graaf Y; Pruijs HE; van Doorne JM; Beemer FA; Helders PJ
Acta Orthop Scand; 1998 Jun; 69(3):283-6. PubMed ID: 9703404
[TBL] [Abstract][Full Text] [Related]
19. Physical activity in youth with osteogenesis imperfecta type I.
Pouliot-Laforte A; Veilleux LN; Rauch F; Lemay M
J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):171-6. PubMed ID: 26032209
[TBL] [Abstract][Full Text] [Related]
20. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
